Abstract

Gene Expression Analysis As a Tool in Early-Stage Oral Cancer Management

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Elective Neck Dissection or Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer Patients: The Dutch Experience.
Daphne Lobeek ... Bart De Keizer
Cancers | VOL. 12
Daphne Lobeek, et. al.Daphne Lobeek ... Bart De Keizer
03 Jul 2020
Effectiveness of sentinel lymph node scintigraphy and intraoperative gamma probing with gold standard elective neck dissection in patients with N0 oral squamous cell cancers.
Palaniswamy Shanmuga Sundaram ... Padma Subramanyam
Nuclear medicine communications | VOL. 40
Palaniswamy Shanmuga Sundaram, et. al.Palaniswamy Shanmuga Sundaram ... Padma Subramanyam
01 Nov 2019
Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer
Deepa Nair ... Sudhir Nair
The New England Journal of Medicine | VOL. 373
Deepa Nair, et. al.Deepa Nair ... Sudhir Nair
06 Aug 2015
Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment.
Michaelina Macluskey ... David I Conway
The Cochrane database of systematic reviews | VOL. 8
Michaelina Macluskey, et. al.Michaelina Macluskey ... David I Conway
31 Aug 2023
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers